Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
DemeRx develops psychedelic-based medications to treat addiction and mental health conditions. The company advances clinical trials for ibogaine and related compounds targeting alcohol use disorder and opioid addiction.
0 investors
DepYmed is a biotech company developing orally bioavailable small-molecule inhibitors of the enzyme PTP1B and copper-chelating compounds as therapeutics for cancer, rare diseases, and conditions such as Rett Syndrome and Wilson Disease. Its pipeline targets protein tyrosine phosphatase signaling pathways implicated in metabolic, inflammatory, and neurodegenerative diseases.
0 investors
DermaMedics develops silicone-based skincare serums built around patented natural antioxidant compounds discovered through skin biochemistry research. Its products target skin concerns such as aging, wrinkles, and free-radical damage for sensitive skin.
0 investors
Dermata develops and distributes direct-to-consumer skincare products based on dermatologic science, offering topical treatments intended to simplify consumers' skincare routines. Its initial planned launch is a once-weekly skin renewal kit, with additional products to follow.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Diagnostic Biochips develops multichannel neural probes for extracellular recording in electrophysiology research, along with cloud-based software for spike sorting and analysis. It serves neuroscience researchers studying the brain at the neural network level.
0 investors
Dialectic Therapeutics is a clinical-stage biotechnology company developing anti-cancer drugs using its Antiapoptotic Protein Targeted Degradation (APTaD) platform, which induces cancer cells to degrade proteins such as BCL-XL. Its lead candidate, DT2216, is in Phase 1/2 trials for fibrolamellar carcinoma and platinum-resistant ovarian cancer.
0 investors
DiaMedica Therapeutics develops therapies aimed at reducing ischemia in patients with serious vascular diseases, with an initial focus on preeclampsia, fetal growth restriction, and acute ischemic stroke. It is a clinical-stage biopharmaceutical company working on treatments for ischemic disorders.
0 investors
DIANT develops proprietary Jet technology and continuous, closed manufacturing systems for producing nanoparticles and lipid nanoparticles (LNPs), and offers R&D through manufacturing services. Its systems serve customers making nanoparticle products for pharmaceuticals, nutraceuticals, food, beverage, and cosmetics.
0 investors
0 investors
0 investors
Diceros Therapeutics develops Verasone, a drug candidate combining two existing therapies for treatment of chronic rhinosinusitis via sinonasal irrigation. The company is advancing the treatment through clinical trials to provide improved efficacy and reduced side effects compared to existing options.
0 investors
CervoMed is a clinical-stage pharmaceutical/biotech company focused on developing drug treatments, progressing candidates from early- to late-stage development toward commercialization.
0 investors
0 investors
0 investors
Dilon Technologies is a medical device manufacturer that develops surgical instruments and diagnostic tools for healthcare practitioners, including gamma probes for lymphatic mapping, margin assessment devices for breast cancer surgery, and video laryngoscopes.
0 investors
Dimer Instruments develops high-performance scientific instruments for biopharmaceutical analysis, using light scattering and biophysical characterization technologies to accelerate drug development processes. The company serves pharmaceutical researchers and drug development teams.
0 investors
0 investors
0 investors